Relationship between abdominal visceral fat and lacunar infarcts in Japanese men

Circulation Journal

Volumn 68, Issue 11, 2004, Pages 982-987

  Nagura, Junko ^a,c   Nakagawa, Yoshio ^b   Miyanaga, Minoru ^b   Matsuoka, Kenji ^b   Hayashi, Kyohei ^a   Ozasa, Kotaro ^a   Watanabe, Yoshiyuki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Kansai Occup Health Association   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Abdominal visceral fat; Cardiovascular risk factors; Lacunar infarct; Magnetic resonance imaging

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; BRAIN INFARCTION; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DRINKING BEHAVIOR; DYSLIPIDEMIA; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; SMOKING; STATISTICAL ANALYSIS;

ABDOMEN; ADIPOSE TISSUE; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN; BRAIN INFARCTION; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; HUMANS; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VISCERA;

EID: 9144225478     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.982     Document Type: Article

References (41)

1. Sacco SE, Whisnant JP, Broderick JP, Phillips SJ, O'Fallon WM. Epidemiological characteristics of lacunar infarcts in a population. Stroke 1991; 22: 1236-1241.
2. Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, et al. Incidence and risk factors for subtypes of cerebral infarction in a general population: The Hisayama study. Stroke 2003; 31: 2616-2622.
3. Davis BR, Vogt T, Frost PH, Burlando A, Cohen J, Wilson A, et al. Risk factors for stroke and type of stroke in persons with isolated systolic hypertension: Systolic Hypertension in the Elderly Program Cooperative Research Group. Stroke 1998; 29: 1333-1340.
4. Iso H, Rexrode K, Hennekens CH, Manson JE. Application of computer tomography-oriented criteria for stroke subtypes classification in a prospective study. Ann Epidemiol 2000; 10: 81-87.
5. You R, McNeil JJ, O'Malley HM, Davis SM, Donnan GA. Risk factors for lacunar infarction syndromes. Neurology 1995; 45: 1483-1487.
6. Gandolfo C, Caponnetto C, Del Sette M, Santoloci D, Loeb C. Risk factors in lacunar syndromes: A case-control study. Acta Neurol Scand 1988; 77: 22-26.
7. Peiris AN, Sothmann MS, Hoffmann RG, Hennes MI, Wilson CR, Gustafson AB, et al. Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med 1989; 110: 867-872.
8. Ferreira SRG, Lerario DDG, Gimeno SGA, Sanudo A, Franco LJ. Japanese-Brazilian Diabetes Study Group: Obesity and central adiposity in Japanese immigrants: Role of the Western dietary pattern. J Epidemiol 2002; 12: 431-438.
9. Fujioka S, Matsuzawa Y, Tokunaga K, Keno Y, Kobatake T, Tarui S. Treatment of visceral fat obesity. Int J Obes 1991; 15(Suppl): 59-65.
10. Marniemi J, Kronholm E, Aunola S, Toikka T, Mattlar CE, Koskenvuo M, et al. Visceral fat and psychosocial stress in identical twins discordant for obesity. J Intern Med 2002; 251: 35-43.
11. Vermeulen A. Ageing, hormones, body composition, metabolic effects. World J Urol 2002; 20: 23-27.
12. Kotani K, Tokunaga K, Fujioka S, Kobatake T, Keno Y, Yoshida S, et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord 1994; 18: 207-212.
13. Ministry of Health, Labour and Welfare, Japan. The National Nutrition Survey in Japan, 2000. Tokyo: Daiichi Press; 2002 (in Japanese).
14. Ministry of Health and Welfare, Japan. The National Nutrition Survey in Japan, 1972 and 1973. Tokyo: Daiichi Press; 1976 (in Japanese).
15. Shimamoto T, Komachi Y, Inada H, Doi M, Iso H, Sato S, et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989; 79: 503-515.
16. Japanese Society of Hypertension Guidelines Subcommittee for the Management of Hypertension. Guidelines for the management of hypertension for general practitioners. Hypertens Res 2001; 24: 613-634.
17. Hata Y, Mabuchi H, Saito Y, Itakura H, Egusa G, Ito H, et al. Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias: Report of the Japan Atherosclerosis Society (JAS) guideline for diagnosis and treatment of hyperlipidemia in Japanese adults. J Atherosder Thromb 2002; 9: 1-27.
18. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, et al. Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus: Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 2002; 55: 65-85.
19. Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. A novel technique for the determination of body fat by computed tomography. Int J Obes 1983; 7: 437-445.
20. Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K, et al. Abdominal fat: Standardized technique for measurement at CT. Radiology 1999; 211: 283-286.
21. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749.
22. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentration of a novel adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599.
23. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935.
24. Kobayashi H, Nakamura T, Miyanaka K, Nishida M, Funahashi T, Yamashita S, et al. Visceral fat accumulation contributes to insulin resistance, small-sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men. Jpn Circ J 2001; 65: 193-199.
25. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002; 360: 57-58.
26. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-946.
27. Berg AH, Combs TP, Du X, Brownlee M, Sherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001; 7: 947-953.
28. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8: 731-737.
29. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003; 361: 226-228.
30. Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction: Implications for syndrome of insulin resistance. J Clin Invest 1996; 97: 2601-2610.
31. Abe H, Yamada N, Kamata K, Kuwaki T, Shimada M, Osuga J, et al. Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substance-1. J Clin Invest 1998; 101: 1784-1788.
32. 2-imbalance in insulin-resistance rat aorta. Diabetes 1999; 48: 2437-2445.
33. Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes 2003; 52: 942-947.
34. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 2000; 102: 1296-1301.
35. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103: 1057-1063.
36. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, et al. Enhanced expression on PAI-1 in visceral fat: Possible contributor to vascular disease in obesity. Nat Med 1996; 2: 800-803.
37. Minematsu K. Lacunar stroke. In: Fisher M, editor. Clinical atlas of cerebrovascular disorders. London: Mosby-year Book Europe; 1994; 8.1-8.17.
38. Zunker P, Schick A, Buschmann HC, Georgiadis D, Nagavi DG, Edelman M, et al. Hyperinsulinism and cerebral microangiopathy. Stroke 1996; 27: 219-223.
39. Japan Society for the Study of Obesity Examination Committee of Criteria for 'Obesity Disease' in Japan. New criteria for 'obesity disease' in Japan. Circ J 2002; 66: 987-992.
40. Iso H, Baba S, Mannami T, Sasaki S, Okada K, Konishi M, et al. Alcohol consumption and risk of stroke amng middole-aged men: The JPHC Study Cohort I. Stroke 2004; 35: 1124-1129.
41. Kinoshita M, Nakaya Y, Harada N, Takahashi A, Nomura M, Bando S, et al. Combination therapy of exercise and angiotensin-converting enzyme inhibitor markedly improves insulin sensitivities in hypertensive patients with insulin resistance. Circ J 2002; 66: 655-658.